The state of Maryland is the global epicenter of vaccine research and development. This has never been more evident than right now as scores of Maryland companies have risen to the global challenge of developing the first approved vaccine for SARS-CoV-2.
Well to say that the first two quarters of 2020 have been eventful in the life science sector is the understatement of the century. The BioBuzz team has been there for every twist and turn as the coronavirus pandemic reshaped everyday life and galvanized the BioHealth Capital Region (BHCR) to rise up and fight COVID-19.
Top Seven Biotech Stock Gains in 2020 Linked to COVID-19
The Top Biotech Companies That are Hiring – June 2020 June 9, 2020 Despite the uncertainty created by the COVID-19 pandemic, companies across the BioHealth Capital Region (BHCR) continue to [….]
COVID-19 Vaccine Progress from 14 BioHealth Capital Region Companies
Coronavirus/COVID-19 Vaccine Insights from Altimmune’s Leadership Team Coronavirus/COVID-19 continues to radically change daily life across the U.S. Governor Larry Hogan issued an executive order on March 15th ordering the closure [….]
Altimmune Becomes The Second Maryland-Based Biotech Advance Potential Coronavirus/COVID-19 Vaccine As the coronavirus COVID-19 continues to spread across the U.S. — there are currently 150 confirmed cases with 11 total [….]
Vaccitech Appoints Bill Enright as New Chief Executive Officer OXFORD, UK, August 27, 2019 / B3C newswire / — Vaccitech, a clinical-stage T cell immunotherapy company developing products to treat and [….]